| Burkitt s lymphoma. | lymphoma, |
| MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors. | gastric, |
| Describes the development of humanized mouse model of MYC/BCL2-driven _double-hit_ lymphoma. By engrafting human HSCs transduced with the oncogene combination into immunodeficient mice, we generate a fatal B malignancy with complete penetrance. | lymphoma, |
| Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies. | lymphoma, |
| Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. | prostate, |
| Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review). | liver, |
| Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma. | liver, |
| Data from knockout mice suggest that Bmyc (brain expressed myelocytomatosis oncogene protein) is a regulator of Myc in vivo and that overexpression of Myc in developing testis leads to increased apoptosis of spermatogenic cells. | brain, |
| SIRT1 expression supports liver tumorigenesis and is closely correlated with oncogenic c-MYC expression. In addition, both SIRT1 and c-Myc may be useful prognostic indicators of hepatocellular carcinoma. | liver, |
| Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma. | kidney, |
| STK38 is a critical upstream regulator of MYC s oncogenic activity in human B-cell lymphoma. | lymphoma, |
| Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells. | leukemia, |
| c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1alpha. | colorectal, |
| Characterization of an embryonal rhabdomyosarcoma cell line showing amplification and over-expression of the N-myc oncogene. | sarcoma, |
| Decitabine represses translocated MYC oncogene in Burkitt lymphoma. | lymphoma, |
| c-myc Oncogene expression in colorectal cancer: its use in prognosis and role in colorectal carcinogenesis. | colorectal, |
| a novel regulatory network in molecular apocrine breast cancers regulated by androgen and AR in which MYC plays a central role as both a key target and a cooperating transcription factor to drive oncogenic growth | breast, |
| Leptin interferes with the expression of oncogenic c-myc and anti-apoptotic bcl-2, and regulates cell turnover and facilitates the progression of cervical cancer. | cervical, |
| Effect of Neem Leaf Extract (Azadirachta indica) on c-Myc Oncogene Expression in 4T1 Breast Cancer Cells of BALB/c Mice. | breast, |
| Amplification of N-myc oncogene in human melanoma cells. | skin, |